Panel: Targeted Radiotherapy and the Impact on IO
PharmaTalkRadio11 Jan 2023

Panel: Targeted Radiotherapy and the Impact on IO

What is the impact of targeted radiotherapy on the immune system?What are the implications for combination IO?Current approaches and future direction Moderated by: Michael Groaning, PhD, Global Medical Affairs Lead, Genitourinary, Amgen Panelists: Charles Glaus, PhD, Sr Director, Radiomics & Radiology Biomarkers, Bayer US-PharmaceuticalsJeff Legos, PhD, MBA, EVP, Global Head of Oncology & Hematology Development , NovartisMatthew Silva, PhD, CEO , InvicroOhad Ilovich, PhD, Senior Director, Translational Sciences, Curie Therapeutics Learn more about the IO360° Summit at www.io360summit.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
rekommandert
liberal-halvtime
sinnsyn
forskningno
tomprat-med-gunnar-tjomlid
villmarksliv
kvinnehelsepodden
tidlose-historier
rss-paradigmepodden
rss-zahid-ali-hjelper-deg
rss-overskuddsliv
dekodet-2
rss-rekommandert
hva-er-greia-med
rss-inn-til-kjernen-med-sunniva-rose
abels-tarn
nevropodden